Of the 451 GRAS notifications voluntarily submitted to the FDA, 22.4% were made by someone directly employed by the company; 13.3% were made by someone directly employed by a firm hand-picked by the company; and 64.3% were made by a panel hand-picked by the corporation or the firm the corporation hired.